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Abstract—Chronic low-grade inflammation is a feature of the pathophysiology of obesity and diabetes in the CNS
as well as peripheral tissues. Glial cells are critical mediators of the response to inflammation in the brain. Key
features of glia include their metabolic flexibility, sensitivity to changes in the CNS microenvironment, and ability
to rapidly adapt their function accordingly. They are specialised cells which cooperate to promote and preserve
neuronal health, playing important roles in regulating the activity of neuronal networks across the brain during
different life stages. Increasing evidence points to a role of glia, most notably astrocytes and microglia, in the sys-
temic regulation of energy and glucose homeostasis in the course of normal physiological control and during dis-
ease. Inflammation is an energetically expensive process that requires adaptive changes in cellular metabolism
and, in turn, metabolic intermediates can also have immunomodulatory actions. Such ‘‘immunometabolic”
changes in peripheral immune cells have been implicated in contributing to disease pathology in obesity and dia-
betes. This review will discuss the evidence for a role of immunometabolic changes in glial cells in the systemic
regulation of energy and glucose homeostasis, and how this changes in the context of obesity and diabetes.
This article is part of a Special Issue entitled: SI: Neuroscience of Obesity Item Group: IG005158.  2019 IBRO. Published by
Elsevier Ltd. All rights reserved.Key words: astrocyte, microglia, inflammation, obesity, diabetes, immunometabolism.INTRODUCTION
Inflammation in the brain is a key feature of disease
pathology seen in experimental models of obesity and
diabetes (De Souza et al., 2005; Thaler et al., 2012). Evi-
dence from human brain imaging studies also supports
the existence of obesity-associated neuroinflammation
in both adults and children (Thaler et al., 2012; Schur
et al., 2015; Berkseth et al., 2018; Sewaybricker et al.,
2019).
In the brain, neuroinflammation is mediated in part by
a class of non-neuronal cells collectively known as glia.
Glia are specialised cells which cooperate to promote
and preserve neuronal health, playing important roles in
regulating the activity of neuronal networks across the
brain during different life stages. A key feature of glia is
their sensitivity to changes in the CNS
microenvironment and the ability to rapidly adapt theirhttps://doi.org/10.1016/j.neuroscience.2019.10.021
0306-4522/ 2019 IBRO. Published by Elsevier Ltd. All rights reserved.
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Nedergaard, 2018). For example, when the CNS is dam-
aged or during disease, glia exhibit reactive gliosis char-
acterised by rapid adaptive changes in form and
function aimed at minimising neuronal damage and
restoring tissue homeostasis (Burda and Sofroniew,
2014). When present chronically, reactive gliosis can con-
tribute to disease pathology. Throughout this review the
term ‘gliosis’ will be used to refer to reactive glial changes
in the CNS, although we acknowledge that glia in the
peripheral and enteric nervous systems are also likely to
show changes in obesity and diabetes.
The aim of this article is to present an overview of the
evidence for the contribution of the principal immune
competent glia, namely astrocytes and microglia, in the
pathology of obesity and diabetes, focusing on the
emerging evidence for a role of metabolic changes in
fuelling their plasticity and inflammatory responses. Other
glia including tanycytes and oligodendrocytes (notably
NG2 glia) have also been studied to a lesser extent in this
context, but will not be highlighted here. The recent
review by Verkrahsky and Nedergaard is an excellent
resource for those seeking comprehensive information on
the cellular physiology of astrocytes (Verkhratsky and
Nedergaard, 2018), while readers are referred to the article
of Wolf and colleagues for a similarly extensive review of
microglial physiology (Wolf et al., 2017).in the Pathophysiology of Obesity and Diabetes. Neuroscience (2019), https://doi.org/10.1016/j.
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are intrinsically linked
The inflammatory response is an energetically expensive
process requiring the synthesis and secretion of new
proteins and in some cases, changes in cellular motility
and morphology. In peripheral immune cells, a diverse
range of metabolic changes essential for their function
have been characterised (O’Neill et al., 2016). Although
the exact nature of these ‘‘immunometabolic” changes
varies according to the cell type examined, they have
been seen consistently across numerous studies. Chronic
exposure to inflammatory stimuli results in metabolic
reprogramming of peripheral immune cells, and emerging
evidence suggests that metabolic intermediates such as
citrate (Williams and O’Neill, 2018) and itaconate
(Hooftman and O’Neill, 2019) can themselves have
immunomodulatory actions.
Obesity and diabetes result in immunometabolic
changes in peripheral immune cells which have been
implicated in disease pathology (Hotamisligil, 2017).
Indeed, metformin which is a first line therapeutic agent
for type-2 diabetes has anti-inflammatory effects
(Vasamsetti et al., 2015; Cameron et al., 2016), some of
which are linked to a role in modulating cellular metabo-
lism (Vasamsetti et al., 2015). This has resulted in inves-
tigation of the therapeutic efficacy of metformin in
autoimmune conditions including lupus and multiple scle-
rosis (Norata et al., 2015).
There is developing evidence that immunometabolic
changes are also seen in glia (most notably microglia
(Paolicelli and Angiari, 2019) and astrocytes (Vicente-
Gutierrez et al., 2019)). Although not yet as comprehen-
sively studied as in peripheral immune cells, these are
potential therapeutic targets for neurological disease.AETIOLOGY OF GLIOSIS IN OBESITY AND
DIABETES
When considering the possible role for immunometabolic
changes in glia in the pathology of obesity and diabetes, it
is important to first discuss the potential causes of gliosis
in metabolic disease. Although most of the studies
mentioned in this section examined animal models of
obesity/type-2 diabetes, there is evidence of CNS gliosis
in streptozotocin (STZ)-induced rodent models of type-1
diabetes (Coleman et al., 2004). However, it is less clear
whether this gliosis is related to the proinflammatory nat-
ure of the STZ treatment and/or the dysregulation of gly-
caemic control seen in these animals.Nutrient composition of the diet
Markers of both microgliosis and astrogliosis have been
observed within the hypothalamus of obese animals and
humans (Horvath et al., 2010; Garcı´a-Ca´ceres et al.,
2011; Fuente-Martı´n et al., 2012; Thaler et al., 2012;
Buckman et al., 2013; Berkseth et al., 2014; Gao et al.,
2014; Schur et al., 2015; 2018). Extra-hypothalamic
changes have also been observed (Pistell et al., 2010;
Buckman et al., 2013), with the hippocampus being the
most studied brain region in this regard. It remains unclearPlease cite this article in press as: Robb JL et al. Immunometabolic Changes in Glia – A Potential Role
neuroscience.2019.10.021whether the effects of obesity on hypothalamic gliosis are
dependent or independent of diet. Several studies
observe hypothalamic gliosis in genetic mouse models
of obesity, characterised by hyperphagia on a standard
chow diet. This gliosis is independent of the animals eat-
ing an obesogenic high-fat high-sucrose (HFHS) diet
(Buckman et al., 2013; Gao et al., 2014) and may be
related to hormonal alterations in these animals (Gao
et al., 2014). In wild-type mice, oral gavage of saturated
fatty acids is sufficient to induce microgliosis but not
astrogliosis in the medial basal hypothalamus
(Valdearcos et al., 2014), resembling microgliosis seen
following consumption of a HFHS diet. However, an inde-
pendent study suggests that it is the combination of high-
fat and high-sucrose in the diet that is an important trigger
for the development of hypothalamic gliosis, as prolonged
consumption of a high-fat low-carbohydrate diet did not
have the same proinflammatory effects (Gao et al.,
2017a). As such, while several independent groups have
demonstrated an effect of obesity on hypothalamic gliosis,
the contribution of specific dietary nutrients in this process
is still unclear.
In mice, diet-induced obesity-associated changes in
hypothalamic astrogliosis appear to be reversible
following weight-loss caused by returning animals to a
standard chow diet or following bariatric surgery
(Berkseth et al., 2014; Herrick et al., 2018). Imaging stud-
ies in humans also indicate improvements in markers of
hypothalamic inflammation following bariatric surgery-
induced weight loss (van de Sande-Lee et al., 2019). It
is unclear whether after weight-loss hypothalamic glia
become ‘primed’ to subsequent inflammatory insults, or
have an altered function which may contribute to the sus-
ceptibility to rebound weight-gain seen in individuals fol-
lowing weight loss. Indeed, in rodents, in utero or
neonatal exposure to a HFHS diet is associated with
microgliosis, microglial priming to subsequent inflamma-
tory insults, and increased susceptibility to the develop-
ment of diet-induced obesity in adulthood (Bilbo and
Tsang, 2010; Ziko et al., 2014).
The age at which mice are placed on an obesogenic
diet appears to be a critical determining factor in the
development of diet-induced hypothalamic gliosis. Mice
which are placed on an obesogenic HFHS diet as
juveniles appear to be relatively resistant to the
development of hypothalamic gliosis, compared with
animals who start the diet later in life (Freire-Regatillo
et al., 2019). These differences may be caused by region
specific age-related changes in glial function, as func-
tional and transcriptomics studies point to differential
activity of metabolic pathways in astrocytes from young
compared with older mice (Clarke et al., 2018; Santos
et al., 2018). It is possible that differences in the age at
which animals were placed on obesogenic diets may
explain the discordance in the results between some pub-
lished studies looking at obesity-associated gliosis.
Peripheral inflammation and changes in the gut
microbiome
Obesity is associated with chronic peripheral low-grade
tissue inflammation, which likely contributes to thein the Pathophysiology of Obesity and Diabetes. Neuroscience (2019), https://doi.org/10.1016/j.
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comorbidities, including cardiovascular and
cerebrovascular disease, cancer, and diabetes.
Changes in the immunometabolic profile of peripheral
immune cells have been reported in animals and people
with obesity and type-2 diabetes (Hotamisligil, 2017).
The gut microbiome is also altered in people with obesity
and is believed to contribute to the changes in peripheral
inflammatory state (Torres-Fuentes et al., 2017).
Whether peripheral inflammatory changes contribute
to CNS inflammation and gliosis in obesity is unclear,
but it is likely to be a contributing factor. Hypothalamic
vascularization and permeability of the blood brain
barrier are increased in obese rodents (Yi et al., 2012),
and select inflammatory cytokines have been shown to
cross the blood brain barrier in high enough concentra-
tions to affect the function of both the barrier and the brain
itself (Pan et al., 2011). As the hypothalamus contains two
circumventricular sites, where the blood brain barrier is
more permeable to entrance of substances from the
periphery, namely the organum vasculosum of the lamina
terminalis (OVLT) and the median eminence, it is proba-
ble that the function of at least the ventral portions of
the hypothalamus are thus impacted. The microbiota-
gut-brain axis may modulate CNS function, either directly
via activity of the vagus nerves or indirectly by altering
peripheral inflammation or modulating neuroendocrine
activity (Torres-Fuentes et al., 2017).
There is evidence from two independent research
groups, including our own, that in mice obesity is
associated with increased migration of peripheral
immune cells into the CNS where they phenotypically
resemble microglia (Buckman et al., 2014; Valdearcos
et al., 2017). Thus, a contribution of these cells to
obesity-associated hypothalamic inflammation/gliosis
cannot be ruled out.
Hypothalamic glial changes are evident within 24 h of
rodents being switched from their standard diet to an
obesogenic HFHS diet (Thaler et al., 2012; Buckman
et al., 2015). This is prior to the onset of chronic white adi-
pose tissue and liver inflammation associated with obe-
sity. This suggests that, at least acutely, hypothalamic
glia are directly responsive to the dietary change. How-
ever, the contribution of an acute transient peripheral
inflammatory response to a HFHS meal cannot be ruled
out.
Neurogenic neuroinflammation
In the hypothalamus, obesity-associated astrogliosis in
adult mice is not uniform. Some hypothalamic nuclei,
such as the dorsomedial hypothalamus (DMH) and the
arcuate (ARC), show profound astrogliosis while other
nuclei, such as the ventromedial nucleus (VMH), are
relatively spared (Buckman et al., 2013). Similarly, regio-
nal differences in obesity-associated hypothalamic
microgliosis have also been reported, with the ARC and
median eminence area being impacted, while the VMH
is again relatively spared (Valdearcos et al., 2017). As
the DMH is not adjacent to a circumventricular site it is
probable that the astrogliosis in this region is not directly
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which may modulate the activity of glia. One possible
explanation is functional differences between glial cells
within the hypothalamus, as regional heterogeneity in glial
cell function in the brain is an emerging area of under-
standing (Cali et al., 2019; Masuda et al., 2019; Polyzos
et al., 2019). Another likely factor is ‘neurogenic neuroin-
flammation’ (Xanthos and Sandkuhler, 2014). Increased
activity of neurons, particularly in response to an intensive
or traumatic stimulus, causes neuronal metabolic stress
which necessitates increased activity of the local glial
cells that help sustain neuronal activity by supplying meta-
bolic support, mediating neurotransmitter recycling, and
maintaining overall tissue homeostasis (Wolf et al.,
2017; Verkhratsky and Nedergaard, 2018). As such,
increased activity of neurons likely results in a concomi-
tant increase in activity of glia in the immediate vicinity.
Further support for neurogenic neuroinflammation as
a likely contributor to obesity-associated gliosis comes
from studies that have examined glial changes
following nutrient insufficiency. In common with
obesity, states of low systemic energy availability in
mice, including fasting (Fuente-Martı´n et al., 2012;
Zhang et al., 2017), caloric restriction (Harrison et al.,
2019), and hypoglycaemia (McDougal et al., 2013),
induce changes in astrocyte morphology and functional
markers indicative of astrogliosis in the brain, in regions
where increased neuronal activity has been reported in
these conditions.
In summary, obesity-associated gliosis has been
observed by several independent research groups in
different experimental models. The causes of this gliosis
are not yet fully elucidated but are likely to be multi-
faceted, encompassing responses to changes within the
brain and the periphery.GLIAL INFLAMMATORY SIGNALLING IS
IMPLICATED THE PATHOLOGY OF OBESITY &
DIABETES
Nuclear factor-kappa B (NF-jB) signalling
The nuclear factor-kappa B (NF-jB) family of
transcription factors regulate the expression of genes
related to cytokine production and cell survival in
inflammatory states (Liu et al., 2017). During non-
inflammatory states NF-jB activity is inhibited by the
IjB proteins. Signalling pathways regulating NF-jB
activity are controlled by a variety of upstream recep-
tors, including Toll-Like Receptors (TLRs), cytokine
receptors and growth factor receptors. Activation of sig-
nalling pathways downstream of these receptors leads
to activation of IKK-b, the catalytic subunit of the IjB
kinase (IKK) complex, which phosphorylates IjB pro-
teins. This results in degradation of IjB, allowing phos-
phorylation and translocation of NF-jB family members
(p50, p52, p65, RelB and c-Rel) to the nucleus where,
when bound as homo- or heterodimers, they act as
transcription factors modulating gene expression. This
is termed the canonical NF-jB pathway. Alternatively,
NF-jB activity can be triggered through the non-
canonical pathway by processing of the C-terminalin the Pathophysiology of Obesity and Diabetes. Neuroscience (2019), https://doi.org/10.1016/j.
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translocation to the nucleus (Liu et al., 2017). For a
review of the functions of NF-jB signalling in different
CNS cell types, the reader is referred to the recent arti-
cle by Dresselhaus and Meffert (Dresselhaus and
Meffert, 2019).
Modulation of nuclear factor-kappa B (NF-jB)
signalling in astrocytes impacts systemic energy
homeostasis
Proteomic profiling of the astrocytic response to
proinflammatory cytokines and the bacterial coat
protein lipopolysaccharide (LPS) suggests that these
stimuli differentially activate the canonical and non-
canonical NF-jB signalling pathways (Dozio and
Sanchez, 2018). In addition to genes involved in inflam-
matory signalling and cell survival, the structural protein
vimentin (Zheng et al., 2005) is an NF-jB target gene;
thus, potentially linking changes in inflammatory sig-
nalling and morphology in astrocytes. Astrocytic
ensheathment of synapses has been implicated in the
modulation of the activity of hypothalamic melanocortin
neuronal circuits regulating feeding behaviour (Horvath
et al., 2010), representing one mechanism by which
changes in astrocyte activity may impact systemic
energy homeostasis.
Genetically mediated inducible-inhibition of NF-jB
signalling in glial-fibrillary acidic protein (GFAP)-
expressing cells (which are predominantly astrocytes),
via expression of a form of IjB that cannot be targeted
for degradation by phosphorylation, prevents acute
hypothalamic astrogliosis in mice fed HFHS-diet for 24 h
(Buckman et al., 2015). This suggests that NF-jB sig-
nalling in astrocytes is responsible, at least in part, for
the acute responsiveness of hypothalamic astrocytes to
a HFHS diet. This study, performed by our group, found
that inhibiting the acute HFHS diet-induced hypothalamic
astrogliosis in mice results in increased food intake, but
only during the acute hyperphagic response to the diet
(first 24 h), suggesting that activation of NF-jB signalling
in astrocytes may be part of a homeostatic response to
deviations from energy homeostasis (Buckman et al.,
2015).
In addition to impacting the acute physiological
response to a HFHS diet, genetic modulation of NF-jB
signalling in astrocytes changes energy homeostasis in
mice chronically consuming this obesogenic diet.
Genetically mediated inducible-deletion of IKKb in
GFAP-expressing cells reduces hypothalamic
astrogliosis in mice previously fed a HFHS diet for
6 weeks (Douglass et al., 2017). Moreover, this leads to
reduced food intake, attenuation of further weight gain
and improved glucose homeostasis in these animals. In
mice, germ-line genetic modification of IKKb activity in
GFAP-expressing cells provides further support for a
key role of this pathway in astrocytic regulation of energy
homeostasis: increased constitutive activity of IKKb in
GFAP expressing cells increases food intake and weight
gain in response to a HFHS diet, while partial ablation
of IKKb activity in these cells shows the opposite effect
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signalling in microglia impacts systemic energy
homeostasis
In common with astrocytes, NF-jB signalling in microglia
can also play a role in regulating energy homeostasis.
Depletion of CNS resident microglia in mice using the
drug PLX5622 reduces food intake and body weight
gain in animals fed a HFHS diet, but not standard chow
(Valdearcos et al., 2017). In a related study, administra-
tion of the anti-mitotic drug arabinofuranosyl cytidine
(AraC) into the brain also blunts food intake and weight
gain on this diet (Andre et al., 2017). The underlying
mechanism is thought to be through preventing HFHS-
induced cell-proliferation, likely encompassing both
microglia and astrocytes. Together, these studies indicate
that microglia likely have a regulatory role in the patho-
physiological response to an obesogenic diet. Genetically
mediated inducible-deletion of microglial IKKb diminishes
HFHS-induced microgliosis, which is accompanied by
reduced weight-gain and food intake, indicating relative
protection from some obesogenic effects of the diet
(Valdearcos et al., 2017). In contrast, the same study
revealed that increasing inflammatory activity in microglia
mimics the hypothalamic microgliosis and weight-gain
associated with HFHS feeding (Valdearcos et al., 2017).
Together, these studies indicate that NF-jB signalling
is a key regulatory node in glial function, the modulation of
which impacts systemic energy homeostasis.Signal transducer and activator of transcription 3
(STAT3) signalling
Signal transducer and activator of transcription 3 (STAT3)
is an important signalling molecule contributing to normal
glial function (Ceyzeriat et al., 2016). Activation of STAT3
signalling, following tyrosine phosphorylation by members
of the Janus kinase family (JAK; Tyr705) or serine phos-
phorylation by a variety of kinases including ERK or
JNK MAP kinase (Ser727), has several potential down-
stream consequences. The classical pathway, following
JAK mediated phosphorylation of Tyr705, results in dimer-
ization of STAT3 and translocation to the nucleus where it
mediates gene transcription. The non-classical pathway,
kinase mediated phosphorylation of Ser727, promotes
STAT3 recruitment to the mitochondrion leading to regu-
lation of cellular metabolism (Yang and Rincon, 2016).
STAT3 signalling is downstream of receptors for cytoki-
nes and the hormone leptin.Glial STAT3 signalling is implicated in the regulation
of food intake and body weight
Several studies implicate STAT3 signalling in astrocytes
in the regulation of systemic energy homeostasis. Leptin
receptors (Ob-Rb) are expressed on astrocytes (Pan
et al., 2008; Hsuchou et al., 2009) and leptin has been
demonstrated to impact astrocyte function in vitro and
in vivo (Hsuchou et al., 2009; Garcı´a-Ca´ceres et al.,
2011; Fuente-Martı´n et al., 2012). Genetically mediated
germ-line deletion of leptin receptors from GFAP-
expressing cells in mice attenuates the inhibitory effectsin the Pathophysiology of Obesity and Diabetes. Neuroscience (2019), https://doi.org/10.1016/j.
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results in enhanced fast-induced refeeding. This suggests
that leptin-signalling in astrocytes plays a role in regulat-
ing neural circuits controlling feeding (Kim et al., 2014).
This is supported by evidence indicating changes in astro-
cyte morphology and synaptic input to hypothalamic mel-
anocortin neurons in these animals (Kim et al., 2014).
There is also evidence to suggest that loss of leptin recep-
tor signalling in astrocytes impacts the pathophysiological
response to diet-induced obesity; however, the phenotype
appears to be complex and variable depending on the
genetic-targeting approach taken, so further clarification
is required (Jayaram et al., 2013; Wang et al., 2015).
As well as astrocytes, leptin receptors are also
expressed on microglia, with leptin treatment modulating
microglial morphology and stimulating cytokine
production and release (Pinteaux et al., 2007; Lafrance
et al., 2010). Genetically mediated germ-line deletion of
leptin receptors from myeloid cells, including microglia,
results in enhanced weight gain on a HFHS diet associ-
ated with attenuation of diet-induced microgliosis in the
paraventricular nucleus of the hypothalamus (PVN) and
alterations in the ARC-PVN melanocortin circuit control-
ling feeding (Gao et al., 2018). This suggests a role for
microglial leptin signalling in regulating neural circuits
controlling feeding.
In addition to activation by leptin, STAT3 can be
phosphorylated through signal transduction downstream
of the interleukin (IL)-6 receptor (IL-6R). IL-6 is an
important pleiotropic cytokine implicated in the central
regulation of energy and glucose homeostasis
(Wallenius et al., 2002; Timper et al., 2017; Mishra
et al., 2019). IL-6 and its receptor are produced and
expressed by both astrocytes and microglia (Erta et al.,
2012). As such, IL-6 (neuronal or glial in origin) may act
in a paracrine or autocrine manner to impact glial function.
Genetically mediated germ-line deletion of IL-6, but not
IL-6R, from GFAP-expressing cells results in a modest
increase in body weight (standard chow diet) in male
but not female mice (Quintana et al., 2013) suggesting
a potential role of astrocyte derived IL-6 in the regulation
of energy homeostasis.AKT signalling
AKT signalling is a pivotal regulator of cellular pathways
throughout the body, implicated in functions from
survival and proliferation to metabolism and growth
(Manning and Toker, 2017). In the context of obesity
and diabetes perhaps the best understood functions of
AKT signalling are those downstream of insulin receptor
activation. Insulin receptors are expressed in the brain
and the action of insulin in the CNS regulates numerous
functions; although, how insulin enters the brain to exert
its actions is a matter of debate (Gray et al., 2014). When
insulin receptors bind insulin, a signalling pathway is initi-
ated by a conformational change to the insulin receptor.
This leads to phosphorylation of PI3-kinase (PI3K) and
subsequent phosphorylation of AKT. Downstream of insu-
lin receptor activation, AKT signalling regulates glucose
and glutamate transporter expression, glucose storagePlease cite this article in press as: Robb JL et al. Immunometabolic Changes in Glia – A Potential Role
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mTOR (Manning and Toker, 2017).Modulation of astrocytic AKT transduction impacts
cellular metabolism and systemic glucose
homeostasis in mice
Within the CNS astrocytes are cellular targets of insulin
action. Human astrocytes in culture express functional
insulin receptors, and inhibition of PI3K-AKT signalling
with LY294002 reduces the insulin-mediated increases
in glycogen synthesis and storage in these cells,
indicating that this pathway is important for regulating
CNS glucose availability (Heni et al., 2011). Recent work
suggests that cooperative action of insulin and insulin-like
growth factor 1 (IGF-1) promotes astrocyte glucose
uptake and may be important for the neural response to
hypoglycaemia (Fernandez et al., 2017). In mouse astro-
cytes, loss of insulin receptor signalling also impacts cel-
lular glucose metabolism, mitochondrial function, and
ATP production (Garcia-Caceres et al., 2016; Cai et al.,
2018).
With respect to systemic energy homeostasis,
genetically mediated inducible-deletion of insulin
receptors from astrocytes increases food intake and
reduces glucose tolerance in mice, an effect that is
recapitulated when deletion of astrocyte insulin
receptors is restricted to the hypothalamus (Garcia-
Caceres et al., 2016). Interestingly, in an independent
study, genetically mediated germ-line deletion of insulin
receptors from mouse astrocytes replicated the mild-
worsening of glucose tolerance, while the effect on food
intake was no longer present (Cai et al., 2018). However,
these animals did demonstrate a depressive-like pheno-
type which was attributed to alterations in dopamine neu-
ronal activity in the mesolimbic system (Cai et al., 2018).
Genetically mediated inducible-deletion of astrocyte
insulin receptors alters astrocyte morphology, which
likely impacts the activity of the hypothalamic
melanocortin circuitry contributing to the effects on
systemic energy homeostasis (Garcia-Caceres et al.,
2016). Evidence suggests that AKT signalling is also
important for regulating expression of glutamate
transporter-1 (GLT-1/excitatory amino acid transporter 2
[EAAT2]), and thus glutamate cycling in astrocytes (Li
et al., 2006; Wu et al., 2010), which may represent
another mechanism by which loss of insulin signalling in
adult astrocytes could impact hypothalamic neuronal
activity. Importantly, the work of Garcı´a-Ca´ceres and col-
leagues also implicates astrocytes in the transport of insu-
lin across the blood brain barrier (Garcia-Caceres et al.,
2016).c-Jun NH2-terminal kinase (JNK) signalling
c-Jun NH2-terminal kinases (JNK) are a family of mitogen
activated protein kinases (MAPKs) which are activated by
multiple stimuli, including pro-inflammatory cytokines
(Zeke et al., 2016). JNKs are activated through phospho-
rylation by several MAPK kinases, including MKK4 and
MKK7 (Tournier et al., 2001; Johnson and Nakamura,
2007). There are three different isoforms of JNK (1–3)in the Pathophysiology of Obesity and Diabetes. Neuroscience (2019), https://doi.org/10.1016/j.
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sity and insulin resistance: JNK1 and 2 activity promoting
disease pathogenesis while JNK3 activity appears to be
protective (Solinas and Becattini, 2017). When consider-
ing data reporting on JNK signalling it is important to be
mindful of the fact that MKK4 also phosphorylates p38
MAPK, resulting in potential crosstalk between the JNK
and p38 MAPK pathways (Zeke et al., 2016).JNK signalling regulates astrogliosis
JNK phosphorylation is associated with increased GFAP
expression in the context of astrogliosis (Cole-Edwards
et al., 2006; Tang et al., 2006; Gadea et al., 2008), medi-
ated in part via AP-1 transcription factor binding to the
GFAP promotor (Gao et al., 2013). This process is depen-
dent on Ca2+ signalling as the Ca2+ chelator BAPTA-AM
reduces both JNK phosphorylation and GFAP accumula-
tion during in vitro scratch assays in mouse primary astro-
cytes (Gao et al., 2013). In addition to regulating GFAP
expression, JNK signalling plays a role in regulating
inflammation in astrocytes. For example, inhibition of
JNK signalling in primary mouse astrocyte cultures with
SP600125 reduces COX-2, IL-6 and iNOS expression in
response to activation by multiple cytokines, including
IL-1b, TNF-a and IFN-c, despite activation NF-jB sig-
nalling remaining (Falsig et al., 2004). Together these
studies indicate that JNK signalling plays an integral role
in astrocyte function during astrogliosis and modulation
of this pathway in glia has been explored as therapeutic
target for neurological disease (Kaminska et al., 2009).Role of astrocyte JNK signalling in mediating insulin
resistance
Although roles for JNK1 signalling in mediating insulin
resistance through inhibition of insulin receptor signalling
is well established in the periphery (Solinas and
Becattini, 2017) and CNS (Belgardt et al., 2010), as yet
there is limited direct data available examining the role
of JNK signalling in glia in the context of obesity insulin
resistance. Diet-induced obesity increases hypothalamic
JNK activity and germ-line deletion of JNK1 from nestin
expressing cells results in protection from diet-induced
glucose intolerance and insulin resistance (Belgardt
et al., 2010). As the intermediate filament protein nestin
is expressed in neural stem cells and reactive astrocytes
(which are a feature of diet-induced obesity in mice) a
contribution of changes in JNK1 signalling in astrocytes
to the phenotype seen cannot be ruled out; particularly
considering the importance of this signalling pathway in
regulating astrogliosis (described above).Links between glial inflammatory signalling and
regulation of cellular metabolism
The specific mechanism(s) by which CNS inflammatory
signalling is activated in glia in obese and/or diabetic
states is unclear. Candidates include direct action of
dietary nutrients (such as saturated fatty acids, as
discussed elsewhere in this review) and cytokines from
endocrine (peripheral tissues/cells), paracrine (neurons,Please cite this article in press as: Robb JL et al. Immunometabolic Changes in Glia – A Potential Role
neuroscience.2019.10.021endothelial cells, pericytes, and neighbouring glia) and/
or autocrine (glia) sources. Diet-induced obesity leads to
an increase in hypothalamic proinflammatory cytokine
expression which is likely to be both glial and neuronal
in origin (De Souza et al., 2005; Thaler et al., 2012).
Genetically mediated microglial depletion attenuates the
inflammatory response to both saturated fatty acids and
LPS in mouse hypothalamic slice cultures (Valdearcos
et al., 2014), indicating that microglia are a primary medi-
ator of the hypothalamic inflammatory response to these
stimuli.
In common with what has been observed in peripheral
tissues, cytokines and other inflammatory stimuli (e.g.
LPS) modulate cellular metabolism in glia (Yu et al.,
1995; Gavillet et al., 2008; Belanger et al., 2011;
Gimeno-Bayon et al., 2014; Nair et al., 2019). For exam-
ple, in vitro treatment of primary mouse cortical astrocytes
with the cytokines TNF-a and IL-1b promotes uptake of
the glucose mimetic 2-deoxyglucose (2DG) and reduces
glycogen stores (Yu et al., 1995; Gavillet et al., 2008;
Belanger et al., 2011). In glia, given that NF-jB (Mauro
et al., 2011), STAT3 (Demaria et al., 2010; Sarafian
et al., 2010), AKT (Pousset et al., 2000; Garcia-Caceres
et al., 2016; Lee et al., 2017; Cai et al., 2018) and JNK
signalling have been independently implicated in regulat-
ing both the response to cytokines and cellular metabo-
lism, it is likely that a localised inflammatory
microenvironment in the hypothalamus (and potentially
other brain regions) leads to glial immunometabolic
changes that modify the function of appetite regulating
neural circuits in this region. The potential role of glial
derived metabolic intermediates in the regulation of these
circuits is discussed in more detail below.
METABOLIC CHANGES IN GLIA ARE
IMPLICATED IN MODIFYING BEHAVIOUR
Glia are metabolically flexible cells which enables them to
be exquisitely sensitive to local changes in the CNS
microenvironment. Astrocytes can also store glycogen
for use as a fuel reserve under conditions of low energy
availability (Brown et al., 2005; Matsui et al., 2012). This
section will highlight how changes in glial metabolism
may play a role in the physiological response to alter-
ations in energy homeostasis in obesity and diabetes.
Glia are directly sensitive to changes in nutrient
availabilityGlucose. Astrocytes express glucose transporters
(GLUT), most notably GLUT1 and GLUT2 (Morgello
et al., 1995; Garcia et al., 2003; Young and McKenzie,
2004), and are critical regulators of brain glucose metabo-
lism (Dienel, 2019). In the hypothalamus, glucose trans-
porter expression is regulated by nutritional state and the
hormones leptin and ghrelin (Fuente-Martı´n et al., 2012,
2016), indicating neuroendocrine integration of systemic
energy status at the cellular level. Modulation of GLUT2
activity has been implicated in the regulation of food
intake and systemic glucose homeostasis in rodents (Marty
et al., 2005; Bady et al., 2006; Stolarczyk et al., 2010).in the Pathophysiology of Obesity and Diabetes. Neuroscience (2019), https://doi.org/10.1016/j.
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sufficient to restore the counterregulatory response to
low-glucose in GLUT2-deficient mice (Marty et al.,
2005), indicating the importance of astrocyte glucose
sensing in this physiological process. This is further sup-
ported by evidence that in astrocytes acute low glucose
levels cause structural and functional changes in astro-
cytes in vitro (Lee et al., 2016) and ex vivo in brainstem
slices (McDougal et al., 2013). Furthermore, work from
our group indicates that recurrent exposure to low glu-
cose, mimicking variations often seen in patients with
insulin-controlled type-1 diabetes, results in metabolic
changes in astrocytes which are likely to be adaptations
to preserve brain ATP production in the face of low glu-
cose availability (Weightman Potter et al., 2019). As out-
lined above, in response to inflammation, on a cellular
level astrocytes show compensatory metabolic adapta-
tions to the altered energetic requirements (Yu et al.,
1995; Gavillet et al., 2008; Belanger et al., 2011).
Like in astrocytes, emerging evidence supports an
intimate relationship between metabolism and
inflammatory responses in microglia (Churchward et al.,
2018; Nair et al., 2019). Microglia are sensitive to
in vitro changes in ambient glucose levels which impact
their function (Hsieh et al., 2019) and express the glucose
transporters GLUT1, GLUT2 and GLUT5 (Payne et al.,
1997). Microglia also express ATP-sensitive K+ (KATP)
channels (Ramonet et al., 2004). Inflammatory stimula-
tion in vitro with LPS and interferon-c results in an adap-
tation of cellular metabolism in microglia towards
glycolysis (Gimeno-Bayon et al., 2014), while inhibition
of glycolysis using 2DG attenuates LPS-induced micro-
glial activation (Shen et al., 2017). Together these data
suggest that in common with macrophages (O’Neill
et al., 2016), glycolytic pathways are important for normal
microglial responses to inflammatory stimuli.Lipids. Glia have been implicated in direct fatty acid
sensing. In response to ingestion (oral gavage) of a diet
rich in this nutrient, saturated fatty acids accumulate in
the medial basal hypothalamus of mice (Valdearcos
et al., 2014), indicating the potential for a direct action of
this nutrient in the brain, particularly at circumventricular
sites. In vitro in primary cultured cells, inflammatory
responses following treatment with saturated fatty acids
have been reported in both astrocytes (Gupta et al.,
2012) and microglia (Wang et al., 2012; Valdearcos
et al., 2014), although when compared head-to-head the
inflammatory response of microglia to this stimulus
appears to be more pronounced (Valdearcos et al.,
2014). Toll-like receptor 4 (TLR4) has been implicated
as a receptor mediating the inflammatory effects of fatty
acids in cells. Indeed, TLR4 signalling in the hypothala-
mus regulates systemic energy balance as intracere-
broventricular injection of a TLR4-inhibiting antibody,
which likely acts in part via receptors found on glia, ame-
liorates leptin resistance in mice fed HFHS diet (Milanski
et al., 2009). However, recent data from macrophages
suggests that, while intact TLR4 signalling is required
for the inflammatory actions of saturated fatty acids,
palmitate is not a direct agonist of this receptorPlease cite this article in press as: Robb JL et al. Immunometabolic Changes in Glia – A Potential Role
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mediated activation, it appears that changes in cellular
metabolism and membrane lipid composition downstream
of TLR4 activation are necessary for the inflammatory
effects of saturated fatty acids (Lancaster et al., 2018).
Both microglia and astrocytes express CD36 and loss
of this the fatty acid transporter impacts glial function
in vitro and in vivo in response to neurological insult
(Bao et al., 2012; Li et al., 2015). This suggests that the
ability to take up and utilise fatty acids as an energy
source is critical for normal glial function in response to
an insult, and is likely related to concomitant immunome-
tabolic responses. In the context of obesity, this phe-
nomenon has been highlighted in the recent work by
Gao et al. (2017b) on lipoprotein lipase (LPL) deficiency
in microglia. LPL, a key enzyme necessary for the break-
down of triglycerides and uptake of fatty acids, is found in
microglia and astrocytes, with higher expression in the
former (Gao et al., 2017b). The levels of microglial lpl
gene expression are increased in diet-induced obese
mice and this is associated with alterations in microglial
metabolism (Gao et al., 2017a; b). Supporting an impor-
tant role for microglia in integrating nutritional cues to reg-
ulate energy homeostasis, loss of LPL from microglia
results in an exacerbation of weight gain (increased adi-
posity) and a worsening of systemic glucose control in
animals fed a HFHS diet (Gao et al., 2017b). This indi-
cates that intact fatty acid uptake by microglia is a key
event in normal microglial function in the context of obe-
sity in mice.
Amino acids. Branched chain amino acids (BCAAs)
can enter the brain through facilitative transport (Smith,
2000) and evidence suggests that the protein composition
of the diet influences amino acid concentrations within the
hypothalamus (Choi et al., 2001). Several studies indicate
that direct infusion of the amino acids leucine or proline
into the medial basal hypothalamus influences systemic
glucose homeostasis in rodents (Su et al., 2012; Arrieta-
Cruz et al., 2013). These effects are mediated via amino
acid metabolism in astrocytes which impacts the produc-
tion of metabolic intermediates by these cells. BCAAs are
an important source of glutamate in the brain via the
action of BCAA-transaminase (Yudkoff, 2017). Glutamate
is a key excitatory neurotransmitter in the brain and glial
regulation of its availability and recycling is critical for nor-
mal brain function (discussed further below). It is likely
that this is achieved via cooperation between neurons
and astrocytes and the balance between the activity of
the glutamate-glutamine and glutamate-BCAA cycles
(Yudkoff, 2017).
Glial-derived metabolic intermediates and products
as signalling moleculesATP. The metabolic endpoint of glycolysis and
mitochondrial metabolism results in ATP generation. In
most cell types ATP, in addition to being used to fuel
biological reactions, is released into the extracellular
space (Dosch et al., 2018). Outside cells, extracellular
ATP (eATP) acts on purinergic receptors, ionotropicin the Pathophysiology of Obesity and Diabetes. Neuroscience (2019), https://doi.org/10.1016/j.
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intracellular calcium and/or activate second messenger
signalling (for review see (Jiang et al., 2017)). Release
of ATP can occur through connexin/pannexin hemi-
channels (Taruno, 2018), vesicular release (Moriyama
et al., 2017), lysosomes (Zhang et al., 2007), and by
direct membrane damage leading to leakage of intracellu-
lar contents. See the review by Franke et al for a compre-
hensive overview of the pathophysiological role of
purinergic signalling in astrocytes, particularly in the regu-
lation of inflammation (Franke et al., 2012). This section
will focus on recent developments in neuroendocrine con-
trol of purinergic signalling and particularly the control of
energy homeostasis.
It is generally accepted that most eATP in the brain
comes from astrocytes (Franke et al., 2012). There are
a number of P2 receptors expressed in the hypothalamus;
for example, orexigenic neuropeptide Y (NPY) and
Agouti-Related Protein (AgRP) neurons express the
P2X2R (Collden et al., 2010) and steroidogenic factor-1
(SF-1) neurons of the VMH, which also are involved in
regulation of feeding, express P2X4, and are excited by
ATP (Jo et al., 2011). In the extracellular space ATP
can be broken down to adenosine, which acts on adeno-
sine receptors. With relevance to feeding behaviour,
chemogenetic activation of hypothalamic astrocytes leads
to ATP release and breakdown to adenosine, which inhi-
bits appetite-stimulating AgRP neurons via activation of
the adenosine A1 receptor (Yang et al., 2015). It should
be noted that in another related study, chemogenetic acti-
vation of astrocytes stimulated feeding (Chen et al.,
2016), with these differences possibly being a result of
subtle differences in experimental design. Recent evi-
dence using astrocyte-specific loss of insulin receptors
suggests that insulin stimulates astrocyte ATP release,
which is a critical step in the anti-depressive actions of
insulin (Cai et al., 2018).
Astrocyte ATP signalling requires a relatively rapid
upregulation of glycolysis to enhance pyruvate
production, that is subsequently used by the
mitochondria to fuel ion handling mechanisms (Juaristi
et al., 2019). Whether this enhanced glycolytic response
to ATP is driven purely by accelerated glycolysis or is also
coupled with enhanced glucose uptake is not clear. In
principle however, ATP has been shown to stimulate glu-
cose uptake in other cell types, including skeletal muscle
(Osorio-Fuentealba et al., 2013) and kidney cells
(Karczewska et al., 2011). In the extracellular space, ade-
nosine is generated from the breakdown of ATP (although
can also be a result of direct adenosine release). Activa-
tion of adenosine 2B receptors (A2BR) increases glucose
uptake into neurons and astrocytes (Lemos et al., 2015).
In rodent astrocytes, activation of A1R and A3R attenu-
ates LPS-induced upregulation of glycolysis genes by
the transcriptional regulator hypoxia-inducible factor 1a
(HIF-1a) (Gessi et al., 2013). These data suggest that in
astrocytes, extracellular ATP and its breakdown products
may play an important role in regulating glucose uptake
and metabolism that influences downstream inflammatory
responses. One enzyme that breaks down eATP, CD73,
is itself regulated by inflammatory cytokines in corticalPlease cite this article in press as: Robb JL et al. Immunometabolic Changes in Glia – A Potential Role
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expression/activity, whilst tumour necrosis factor a
(TNF-a) increases expression/activity (Brisevac et al.,
2012). This indicates a degree of signal specificity to
changes in ATP breakdown extracellularly, plausibly to
allow for resolution of inflammation/injury.
Lactate. Lactate is released from astrocytes either as
a direct product of glycolysis or from the breakdown of
small amounts of stored glycogen. In diabetes,
specifically in the context of recurrent insulin-induced
hypoglycaemia, VMH lactate levels are significantly
increased and likely contribute to counterregulatory
failure (Borg et al., 2003; Chan et al., 2013). Whether this
lactate alters subsequent glial immunometabolic
responses relevant to glucose control remains to be
determined; however, in separate studies lactate has
been demonstrated to influence glial cytokine secretion.
For example, in microglial and astrocyte cultures, lactate
can induce IL-1b, IL-6 and TNFa secretion from microglia
and IL-1b and IL-6 secretion from astrocytes (Andersson
et al., 2005). It should be noted that this occurred with
high concentrations of lactate (>10 mM) over 8 hours,
suggesting this may only happen in relatively extreme
pathophysiological contexts. It has also been reported
that TNFa and IL-1a can increase astrocyte glucose
uptake and utilisation, without an increase in lactate pro-
duction, suggesting that the additional carbon is being
shuttled towards the tricarboxylic acid cycle (TCA) or
the pentose phosphate pathway (PPP) (Yu et al., 1995).
This is supported by evidence demonstrating a large
increase in both TCA and PPP activity in primary mouse
astrocytes treated with IL1-b and TNFa with only a mod-
est, non-significant trend toward reduced lactate release
(Gavillet et al., 2008). In a Wistar rat neonatal overnutri-
tion model, increased hypothalamic lactate transporter
expression, in addition to increases in glucose and gluta-
mate transporter expression (Fuente-Martin et al., 2013)
were reported. The addition of sucrose at weaning, sub-
sequent to neonatal overnutrition, also increased serum
IL-1b and IL-6 levels and hypothalamic IL-6 mRNA levels
(Fuente-Martin et al., 2013). Although these data are not
indicative of a role of lactate in neuroinflammation per se,
when taken together with the data above they suggest
that lactate levels are modestly influenced by the inflam-
matory state, rather than lactate being a driver of the
process.
Ketone bodies. Ketone bodies are produced in the
mitochondria from acetyl-CoA generated primarily from
fatty acid oxidation, dependent on the rate-limiting
enzymes 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA)
synthase and HMG-CoA lyase (Hegardt, 1998;
Grabacka et al., 2016). While predominantly synthesised
in the liver, astrocytes also produce ketone bodies from
fatty acids derived from dietary lipids (Le Foll et al.,
2014, 2015). While other areas of the brain can also pro-
duce ketones, this appears to be enriched in the hypotha-
lamus (Le Foll et al., 2014). In the brain, ketogenesis
occurs predominantly in astrocytes which are also the
principle oxidisers of fatty acids (Edmond et al., 1987;in the Pathophysiology of Obesity and Diabetes. Neuroscience (2019), https://doi.org/10.1016/j.
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et al., 2019). Both increased dietary fatty acid intake and
decreased glucose availability/AMP-activated protein
kinase activation can increase astrocytic ketogenesis
(Edmond et al., 1987; Blazquez et al., 1999; Le Foll
et al., 2014). In fact, more than half of the energy used
by neurons during fasting is derived from ketones
(Cahill, 2006). Therefore, in both high and low energy
states ketogenesis occurs and can act as a signal to reg-
ulate food intake. In the context of high fat diets, for exam-
ple, astrocyte derived ketones can be shuttled to neurons
via monocarboxylate transporters where they are metabo-
lised to generate ATP. In this way, they could override
normal fatty acids sensing by CD36 via closing KATP
channels and depolarising the cell, thus activating fatty
acid-sensing neurons (Le Foll and Levin, 2016). The acti-
vation of these fatty acid-sensing neurons by ketones
suppresses food intake in both acute HFHS diet fed and
diet-induced obese rodent models (Le Foll and Levin,
2016). This is supported by the finding that inhibition of
VMH ketone production in rats increases food intake (Le
Foll et al., 2015).
In addition to promoting weight loss, ketogenic diets
are reported to improve symptoms in several
neurological disorders (Yang et al., 2019), including epi-
lepsy (Rho et al., 2019), Alzheimer’s disease (Reger
et al., 2004), Parkinson’s disease (Vanitallie et al.,
2005), and traumatic brain injuries (White and
Venkatesh, 2011). The protective effects of ketones are
thought to be mediated in part by immune-modulatory
actions. For example, b-hydroxybutyrate blocks the NLR
Family Pyrin Domain Containing 3 (NLRP3) inflamma-
some (Youm et al., 2015), which mediates the release
of pro-inflammatory cytokines IL-1b and IL-18 in brain
(Yatsiv et al., 2002; de Rivero Vaccari et al., 2009; Li
et al., 2011). It is hypothesised that ketone-induced inhibi-
tion of NLRP3 suppresses innate immune responses dur-
ing starvation to spare ATP generated for maintenance of
cell function (Youm et al., 2015). Interestingly, NLRP3
contributes to the onset of type 2 diabetes by increasing
insulin resistance, which can be attenuated by ablation
of NLRP3 (Vandanmagsar et al., 2011; Wen et al., 2011).Glutamate/glutamine. Astrocytes recycle glutamate
from the synapse to regulate neurotransmission and
prevent excitotoxicity (Verkhratsky and Nedergaard,
2018). Briefly, astrocytes sequester glutamate from the
synapse via GLT-1/EAAT2 or glutamate aspartate trans-
porter (GLAST/EAAT1). Glutamate is then converted to
glutamine by glutamine synthase where it is either fur-
ther metabolised by astrocytes via the TCA cycle or trans-
ported back to neurons via system-N amino acid
transporters (SNATs). Once glutamine has re-entered
the neuron, phosphate activated glutaminase (PAG) con-
verts it to glutamate where it can be repackaged into vesi-
cles in preparation for neurotransmitter release. Microglia
also take up glutamate via GLT-1/EAAT2 where it is con-
verted to glutathione which is an important defence
against reactive oxygen species (ROS) (Persson et al.,
2006). The uptake of glutamate by astrocytes and micro-
glia is metabolically expensive, requiring activity of thePlease cite this article in press as: Robb JL et al. Immunometabolic Changes in Glia – A Potential Role
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demand, evidence suggests that astrocytes increase gly-
colysis and lactate production within seconds of exposure
to glutamate (Pellerin and Magistretti, 1994).
In states of high neuronal activity or damage,
excessive demands on astrocytes to sequester
neurotransmitters like glutamate can negatively impact
their ability to do so. For example, in rats normal
hypoglycaemia-induced glutamate release in the VMH is
suppressed after repeated-hypoglycaemia, attributed in
part to a decrease in astrocyte glutamate uptake
(Chowdhury et al., 2017). Therefore, the normal gluta-
matergic response to a decrease in glucose is attenuated,
delaying the onset of the normal counterregulatory
response to hypoglycaemia (Chowdhury et al., 2017).
On the other end of the energy homeostasis spectrum,
intake of an obesogenic HFHS diet rapidly increases
hypothalamic glutamatergic signalling (Guyenet et al.,
2013) and expression of astrocytic glutamate transporter
expression (Fuente-Martı´n et al., 2012). Furthermore,
chronic intake of a HFHS diet alters microglial expression
of genes associated with glutamate metabolism such that
the normal antioxidant effects of glutamate-derived glu-
tathione are suppressed, increasing ROS production
(Milanova et al., 2019). It is possible that chronically ele-
vated glutamatergic signalling associated with diet-
induced obesity increases the metabolic demand on both
microglia and astrocytes to prevent excitotoxicity. This in
turn negatively impacts their ability to support neuronal
activity; thus, contributing to hypothalamic synaptic dys-
function and the death of ARC POMC neurons (Horvath
et al., 2010; Thaler et al., 2012; Reis et al., 2015).
Reactive oxygen species. Reactive oxygen species
(ROS) are a by-product of mitochondrial activity and at
high levels can cause oxidative stress in the cell.
Despite the negative impact of excess ROS on cellular
stress, ROS production by astrocytes may have a role
in regulating normal CNS function (Vicente-Gutierrez
et al., 2019). Astrocytes cultured from mice with
astrocyte-specific down-regulation of ROS production
had altered cellular metabolism: glycolysis was reduced
while activity of the PPP increased, and a lower NADPH
(H+)/NADP+ ratio was observed. In vivo, mice with
reduced astrocytic ROS production displayed altered neu-
ronal dendrite projections in the hippocampus and parietal
cortex, alongside cognitive impairment (Vicente-Gutierrez
et al., 2019). While accumulation of ROS can be patho-
logical when dysregulated, this aforementioned study
and others (Angelova and Abramov, 2016) implicate
astrocytic ROS production as a part of normal physiolog-
ical regulation of cellular signalling pathways.
FUTURE PERSPECTIVES
In common with peripheral immune cells, accumulating
evidence suggests that immunometabolic changes in
glia may be instrumental in the pathophysiology of
obesity and diabetes. Additional work is required to
understand the full spectrum of these responses,
particularly with respect to the molecular mechanisms
by which hormones and nutrients impact glial function,in the Pathophysiology of Obesity and Diabetes. Neuroscience (2019), https://doi.org/10.1016/j.
Fig. 1. A simplified schematic diagram of the proposed immunometabolic changes in astrocytes which
may contribute to the CNS regulation of energy homeostasis – A variety of inputs, including nutritional
stimuli (glucose, fatty acids, and branch chain amino acids [BCAA]), hormones (leptin and insulin) and
cytokines can directly regulate cellular signalling and metabolic pathways in astrocytes. The signalling
pathways implicated include signal transducer and activator of transcription 3 (STAT3), AKT, c-Jun N-
terminal kinase (JNK) and nuclear factor kappa B (NF-jB), which in turn can impact astrocyte
metabolism by modulating transcription or translation of key regulatory components of glycolysis and
mitochondrial metabolism.Depending on the signalling pathway(s) activated and theenergetic status of
the cell, which is directly impacted by the CNS microenvironment, this leads to changes in levels of
metabolic intermediates andproducts: lactate, ketones, reactive oxygen species (ROS), glutamine, and
ATP. When released from the cell, these factors are capable of modulating synaptic transmission and
function of neurons in energy homeostasis circuits in theCNS.Activation of astrocyte signalling canalso
lead to the production of cytokines, which may act in an autocrine or paracrine fashion to modulate
neuronal and glial activity, potentially perpetuating a CNS proinflammatory microenvironment, such as
in obesity or diabetes. In addition tomodulating release of biochemical signalling modules, activation of
astrocyte signalling can lead to changes in expression of structural proteins in astrocytes, such as glial-
fibrillary acidic protein (GFAP), which enable morphological changes in astrocytes which impact
neuronal transmission via ensheathment of synapses.
10 J. L. Robb et al. / Neuroscience xxx (2019) xxx–xxxand how these glial changes in turn impact synaptic
transmission and neuronal function. In this review we
have focused on highlighting some of the key signalling
pathways and metabolic processes that may be
involved (see Fig. 1 for a summary of astrocytic
changes, many of which are also applicable to
microglia). Much of our current understanding of
immunometabolic responses in glia comes from in vitro
studies on isolated cell types in culture which, while
informative, cannot fully recapitulate the complex
interactions between glia and neurons in the in vivo
environment. Studies examining mice with genetic
modification of glial function have begun to reveal a key
role for these cells in modulating neuronal circuitry
regulating energy homeostasis; however, compared with
neurons, the available tools for specific inducible-
modulation of glial cell function are limited which is
currently restricting the ability to elucidate the spatial–
temporal dynamics of glial modulation of neural circuits.
Another challenge in the field is the fact that we still
know little about regional heterogeneity in glial function,
both generally and with respect to their role in
modulating neural circuits controlling energy
homeostasis. To date most of the work on glial
modulation of CNS circuits regulating energyPlease cite this article in press as: Robb JL et al. Immunometabolic Changes in Glia – A Potential Role in the Pathophysiology of Obesity a
neuroscience.2019.10.021homeostasis has focused on the
hypothalamus, with other key
areas such as the dorsal-vagal
complex of the brainstem and
mesolimbic reward pathways
being comparatively understudied.
In the context of obesity and
diabetes an improved
understanding of how (and where)
changes in glial function are
initiated and regulated is needed,
before we can consider
developing therapeutic
interventions targeting this
system. This should be
complemented by continued
efforts to understand how glia
contribute to the regulation of
systemic energy homeostasis in
the course of normal physiology.
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